HOBSCOTCH for People With Post Acute COVID-19 Syndrome (PACS)

Dartmouth Health

Status: Active, not recruiting

Conditions: Memory Dysfunction; Post Acute COVID 19 Syndrome; Cognitive Dysfunction; Memory Impairment

Treatments: Behavioral: HOBSCOTCH-PACS

Study type: Interventional

Funder types: Other

Identifiers

NCT06391489

STUDY 02002402

Details and patient eligibility

About

The goal of this pilot study is to assess the feasibility of adapting and delivering the existing home-based epilepsy self-management intervention, HOBSCOTCH, for people with Post Acute Covid Syndrome (PACS).

The main questions it aims to answer are:

Can the current HOBSCOTCH program be adapted for people with PACS?

Will people with PACS experience improved quality of life similar to that found in people with epilepsy after participating in the HOBSCOTCH program?

Participants will be asked to:

• attend nine, one-hour virtual (online and/or by telephone) HOBSCOTCH-PACS sessions with a one-on-one certified HOBSCOTCH-PACS coach
• complete a brief clinical questionnaire about their diagnosis of PACS
• complete seven questionnaires before and after the HOBSCOTCH-PACS sessions about their quality of life, memory and thinking processes (objective and subjective cognition), about their physical and mental health and about autonomic symptoms associated with their diagnosis of PACS
• keep a short daily diary (using a smart phone app or on paper) about their PACS symptoms and use of the self-management strategies taught in the HOBSCOTCH-PACS program
• complete two brief surveys to assess satisfaction with their experience after the entire HOBSCOTCH-PACS program

Enrollment: 10 patients

Sex: All

Ages: 20 to 65 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Literate, English-speaking with grade 12 or equivalent in education
• Self-reported diagnosis of PACS
• Self-reported cognitive/memory difficulties
• Telephone and internet access

Exclusion criteria

• Cognitive dysfunction that precludes participation in giving informed consent
• Significant visual impairment precluding reading or writing
• No reliable telephone or internet access
• Neurodegenerative illness (i.e. dementia)
• Acute psychiatric disease

Trial design

Primary purpose: Other

Allocation: N/A

Interventional model: Single Group Assignment

Masking: None (Open label)

---

10 participants in 1 patient group

PACS Participant With Cognitive and Memory Dysfunction

Other group

Description:

Participants will receive the HOBSCOTCH-PACS intervention consisting of 1:1 sessions delivered once per week including: 1 pre-HOBSCOTCH Session (on webcam or by phone) 1 educational session (on webcam) 6 HOBSCOTCH intervention sessions (webcam or phone) 1 wrap-up session (webcam or phone)

Treatment:

Behavioral: HOBSCOTCH-PACS